plat

(redirected from tissue plasminogen activator)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to tissue plasminogen activator: streptokinase

plat

A plan or survey map of a parcel of land.Developers file subdivision plats showing block and lot numbers, the dimensions and locations of individual lots, and the dimensions and locations of dedicated streets. Legal descriptions for properties within the subdivision are then made by reference to the recorded plat,such as “Lot 2,Block 3 of Harper Downs II as recorded in Plat Book 213,Page 82, of the Judge of Probate of Jefferson County,Alabama.”

References in periodicals archive ?
Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
Clinical outcomes among stroke patients receiving tissue plasminogen activator therapy beyond the 3-hour time window.
Optimizing refolding condition for recombinant tissue plasminogen activator.
Referral sources of patients receiving tissue plasminogen activator (tPA) and those managed conservatively.
Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs.
Research published in the December 2009 issue of The Lancet Neurology suggests there is good evidence for extending the window for treating a stroke with tissue plasminogen activator (tPA) to four-and-a-half hours from its current three hours.
Six of the 10 previously documented cases were associated with streptokinase use rather than recombinant tissue plasminogen activator (Reteplase), as in our patient, but this is probably due to streptokinase being an older agent.
Tissue plasminogen activator and total cholesterol decreased, and high-density lipoprotein increased.
Ideally, patients should get to the hospital within one hour to allow time for diagnosis and treatment with tissue plasminogen activator (t-PA) in case of a clot-caused stroke.